EUVIMEDEUVIMED entdecken
Crossref

L26/P-203 Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in non-male factor preimplantation genetic testing for aneuploidy (PGT-A) cycles: a retrospective analysis

C. Vitiello, V.K. Hua, A. Murray, R. Lahoud, N. Hesketh

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C. Vitiello und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can conventional in vitro fertilisation (IVF) be an alternative to intracytoplasmic sperm injection (ICSI) in preimplantation genetic testing for aneuploidy (PGT-A) without male factor infertility? Summary answer These findings support the use of conventional IVF as a valid fertilization strategy in PGT-A cycles without male factor infertility. What is known already Intracytoplasmic sperm injection (ICSI) is widely adopted in PGT-A cycles to reduce the theoretical risk of paternal DNA contamination, even in couples without male-factor infertility. However, conventional IVF allows physiological sperm selection and has demonstrated comparable effectiveness to ICSI in non-male factor patients, with similar embryo development, euploidy rates, and clinical outcomes. Recent studies in PGT settings suggest comparable chromosomal and reproductive outcomes between IVF and ICSI, but evidence remains limited and varied, and the clinical relevance of the insemination method in PGT-A cycles is still debated. Study design, size, duration This retrospective cohort study included all non-male factor PGT-A freeze-all cycles performed between 1 January 2022 and 31 December 2024 in one centre. Baseline characteristics were broadly comparable. A total of 3,674 embryos from 1,241 cycles were analysed to compare euploidy rates between IVF and ICSI. Additionally, 1,018 frozen embryo transfers (FETs) (771 IVF and 247 ICSI) within the same period were evaluated for clinical outcomes. Donor cycles and imported embryos were excluded. Participants/materials, setting, methods Multivariable logistic regression models were used to assess differences between IVF and ICSI in terms of embryo euploidy, clinical pregnancy (CP), and live birth rates (LBR). Separate models were constructed for each outcome, with insemination method as the primary exposure. Results were reported as odds ratios with 95% confidence intervals. Robust standard errors were estimated by clustering at the treatment cycle level to account for intra-cycle correlation. Statistical significance was set at p < 0.05. Main results and the role of chance After adjustment for potential confounders, including cycle number, maternal age, body mass index (BMI), embryo quality, embryo stage, day of embryo culture, number of oocytes with two pronuclei (2PN), sperm concentration, and sperm motility, no significant differences were observed in euploidy, clinical pregnancy (CP), or live birth rate (LBR) between ICSI and IVF in PGT-A cycles. Euploidy rates did not differ significantly between the two groups (ICSI:519/897 [57.9%] vs IVF:1,620/2,777 [58.3%]; OR 0.94, 95% CI 0.78–1.13; p = 0.5). Clinical pregnancy, defined as ultrasound visualization of a gestational sac, also did not differ between groups (ICSI:126/247 [51.0%] vs IVF:419/771 [54.3%]; OR 0.91, 95% CI 0.70–1.18; p = 0.5). Similarly, live birth rates were comparable between ICSI and IVF (ICSI:103/247 [41.7%] vs IVF:356/771 [44.9%]; OR 0.93, 95% CI 0.71–1.23; p = 0.6) Limitations, reasons for caution This was a retrospective, non-randomised single-centre study, therefore residual confounding and selection bias cannot be excluded. Differences in laboratory protocols or clinical management over time may have influenced outcomes. The smaller ICSI FET sample may limit power to detect small differences. Wider implications of the findings In non-male factor PGT-A freeze-all cycles, ICSI does not confer advantages over conventional IVF in terms of euploidy, clinical pregnancy, or live birth. These results support an IVF-first approach and may help reduce unnecessary ICSI use, improving cost-effectiveness and optimising embryology laboratory workload without compromising outcomes. Trial registration number No

Zitieren

APA

Vitiello, C., Hua, V., Murray, A., Lahoud, R., & Hesketh, N. (2026). L26/P-203 Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in non-male factor preimplantation genetic testing for aneuploidy (PGT-A) cycles: a retrospective analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.539

Vancouver

Vitiello C, Hua V, Murray A, Lahoud R, Hesketh N. L26/P-203 Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in non-male factor preimplantation genetic testing for aneuploidy (PGT-A) cycles: a retrospective analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.539

BibTeX
@article{Vitiello2026,
  author = {Vitiello, C. and Hua, V.K. and Murray, A. and Lahoud, R. and Hesketh, N.},
  title = {L26/P-203 Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in non-male factor preimplantation genetic testing for aneuploidy (PGT-A) cycles: a retrospective analysis},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.539}
}
Kostenlos starten →